Chemotherapy and Atezolizumab for Patients with Extensive Stage Small Cell Lung Cancer (SCLC) with Untreated Brain Metastases (HCRN-LUN19-247)

Administered By

Awarded By

Contributors

Start/End

  • December 7, 2020 - November 30, 2025